ETHEMA HEALTH Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Greene Eileen Maria, was filed 22 Nov 2024.
Since the insiders bought
- -80.0%Entry US$0.00 · Close at T+365 US$0.00
- -56.3%Entry US$0.00 · Close at T+365 US$0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000,000 shares@ US$0.00050.5% of flowCommon StockSEC:0001903596-24-000690:1Canonical exit: 19 Feb 2025 (T+90)
- 34,092,551 shares@ US$0.00051.9% of flowCommon StockSEC:0001903596-24-000690:0Canonical exit: 18 Feb 2025 (T+90)
- 1,000,000,000 shares@ US$0.000554.1% of flowCommon StockSEC:0001903596-24-000432:0Canonical exit: 10 Oct 2024 (T+90)
- 3,000,000,000 shares@ US$0.0005100.0% of flowCommon StockSEC:0001903596-24-000433:0Canonical exit: 10 Oct 2024 (T+90)
- 5,000,000 shares@ US$0.00060.3% of flowCommon StockSEC:0001903596-24-000392:1Canonical exit: 18 Sept 2024 (T+90)
- 5,000,000 shares@ US$0.00060.3% of flowCommon StockSEC:0001903596-24-000392:0Canonical exit: 16 Sept 2024 (T+90)
- 26,425,000 shares@ US$0.04Common StockSEC:0001903596-24-000382:1Canonical exit: 4 Sept 2024 (T+90)
- 26,425,000 shares@ US$0.00041.1% of flowCommon StockSEC:0001903596-24-000383:1Canonical exit: 4 Sept 2024 (T+90)
- 10,005,000 shares@ US$0.0443.3% of flowCommon StockSEC:0001903596-24-000382:0Canonical exit: 3 Sept 2024 (T+90)
- 10,005,000 shares@ US$0.00040.4% of flowCommon StockSEC:0001903596-24-000383:0Canonical exit: 3 Sept 2024 (T+90)
- 28,350 shares@ US$0.079Common StockSEC:0001721868-18-000742:0Canonical exit: 19 Feb 2019 (T+90)
11 of 11 declarations
About ETHEMA HEALTH Corp
ETHEMA HEALTH Corp has only 11 filings, all purchases, published between December 12, 2018 and November 22, 2024, and two filers: Eileen Maria Greene (9 filings) and Shawn Edward Leon (CEO, 2). The record holds no sale, no grant and no option exercise.
The 11 purchases (9 with an amount) total EUR 2,247,264, with a median of EUR 9,702. Almost everything happens from June 18, 2024 to July 12, 2024, when the 2 insiders bought for EUR 1,845,055. The largest purchase is Shawn Edward Leon's, EUR 1,379,595 on July 12, 2024; Eileen Maria Greene bought for EUR 459,865 the same day and for EUR 368,016 on June 5, 2024.
Read moreShow less
Annual volume is 10 filings in 2024 and 1 in 2018, with none in the years between. No filing falls in the last twelve months. The median publication delay is 6 days. Insiders hold 54% of the capital of this US healthcare and pharma company.
